(1)
Borowiec, A.; Właszczuk, A.; Olakowska, E.; Lewin-Kowalik, J. TXNIP Inhibition in the Treatment of Diabetes. Verapamil As a Novel Therapeutic Modality in Diabetic Patients. Medicine and Pharmacy Reports 2022, 95, 243-250.